Showing results (281-290 of 329) with videos related to
Sort By:
Pageof 33
Optics Letters|August 19, 2008
Three-dimensional molecular mapping in a microfluidic mixing device using fluorescence lifetime imagingTom Robinson, Prashant Valluri, Hugh B Manning, et al.The Lancet. Respiratory Medicine|October 28, 2023
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.AIDS (London, England)|February 9, 2016
Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatmentHans-Jürgen Stellbrink, Eric Le Fevre, Andrew Carr, et al.Clinical Drug Investigation|November 25, 2021
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaKatja Weisel, Thomas Martin, Amrita Krishnan, et al.NPJ Precision Oncology|March 26, 2025
ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trialThomas J Herzog, Thomas C Krivak, Stephen Bush, et al.Translational Oncology|March 21, 2020
Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case SeriesTulika Ranjan, Candace M Howard, Alexander Yu, et al.Current Medical Research and Opinion|October 22, 2022
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myelomaTom Martin, Saad Z Usmani, Jordan M Schecter, et al.The Pediatric Infectious Disease Journal|October 13, 2017
Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1Carlo Giaquinto, Muthuhadini Patience Mawela, Kulkanya Chokephaibulkit, et al.European Journal of Endocrinology|August 3, 2021
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDYMaria Fleseriu, Dagmar Führer-Sakel, Aart J van der Lely, et al.JCI Insight|July 8, 2021
Reduced thyroxine production in young household contacts of tuberculosis patients increases active tuberculosis disease riskKamakshi Prudhula Devalraju, Deepak Tripathi, Venkata Sanjeev Kumar Neela, et al.Pageof 33